208 related articles for article (PubMed ID: 25724651)
21. Identification of protease-sensitive sites in Human Endothelial-Monocyte Activating Polypeptide II protein.
Liu J; Schwarz MA
Exp Cell Res; 2006 Jul; 312(12):2231-7. PubMed ID: 16674941
[TBL] [Abstract][Full Text] [Related]
22. The tRNA-dependent activation of arginine by arginyl-tRNA synthetase requires inter-domain communication.
Lazard M; Agou F; Kerjan P; Mirande M
J Mol Biol; 2000 Sep; 302(4):991-1004. PubMed ID: 10993737
[TBL] [Abstract][Full Text] [Related]
23. Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation.
Journeay WS; Janardhan KS; Singh B
Inflamm Res; 2007 May; 56(5):175-81. PubMed ID: 17393072
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.
Murray JC; Barnett G; Tas M; Jakobsen A; Brown J; Powe D; Clelland C
Am J Pathol; 2000 Dec; 157(6):2045-53. PubMed ID: 11106577
[TBL] [Abstract][Full Text] [Related]
25. Structure of the EMAPII domain of human aminoacyl-tRNA synthetase complex reveals evolutionary dimer mimicry.
Renault L; Kerjan P; Pasqualato S; Ménétrey J; Robinson JC; Kawaguchi S; Vassylyev DG; Yokoyama S; Mirande M; Cherfils J
EMBO J; 2001 Feb; 20(3):570-8. PubMed ID: 11157763
[TBL] [Abstract][Full Text] [Related]
26. The cytokine portion of p43 occupies a central position within the eukaryotic multisynthetase complex.
Norcum MT; Warrington JA
J Biol Chem; 2000 Jun; 275(24):17921-4. PubMed ID: 10787402
[TBL] [Abstract][Full Text] [Related]
27. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7.
Behrensdorf HA; van de Craen M; Knies UE; Vandenabeele P; Clauss M
FEBS Lett; 2000 Jan; 466(1):143-7. PubMed ID: 10648830
[TBL] [Abstract][Full Text] [Related]
28. Translation initiation from two in-frame AUGs generates mitochondrial and cytoplasmic forms of the p43 component of the multisynthetase complex.
Shalak V; Kaminska M; Mirande M
Biochemistry; 2009 Oct; 48(42):9959-68. PubMed ID: 19775078
[TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH.
Chang SY; Ko HJ; Heo TH; Kang CY
Mol Pharmacol; 2005 May; 67(5):1534-43. PubMed ID: 15710745
[TBL] [Abstract][Full Text] [Related]
30. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
31. Aminoacyl tRNA synthetase complex interacting multifunctional protein 1 simultaneously binds Glutamyl-Prolyl-tRNA synthetase and scaffold protein aminoacyl tRNA synthetase complex interacting multifunctional protein 3 of the multi-tRNA synthetase complex.
Schwarz MA; Lee DD; Bartlett S
Int J Biochem Cell Biol; 2018 Jun; 99():197-202. PubMed ID: 29679766
[TBL] [Abstract][Full Text] [Related]
32. Cloning and expression of human endothelial-monocyte-activating polypeptide 2 (EMAP-2) and identification of its putative precursor.
Tas MP; Houghton J; Jakobsen AM; Tolmachova T; Carmichael J; Murray JC
Cytokine; 1997 Aug; 9(8):535-9. PubMed ID: 9245479
[TBL] [Abstract][Full Text] [Related]
33. Regulation of EMAP II by hypoxia.
Matschurat S; Knies UE; Person V; Fink L; Stoelcker B; Ebenebe C; Behrensdorf HA; Schaper J; Clauss M
Am J Pathol; 2003 Jan; 162(1):93-103. PubMed ID: 12507893
[TBL] [Abstract][Full Text] [Related]
34. Degradation of AIMP1/p43 induced by hepatitis C virus E2 leads to upregulation of TGF-β signaling and increase in surface expression of gp96.
Kim MS; Kim S; Myung H
PLoS One; 2014; 9(5):e96302. PubMed ID: 24816397
[TBL] [Abstract][Full Text] [Related]
35. Web-ware bioinformatical analysis and structure modelling of N-terminus of human multisynthetase complex auxiliary component protein p43.
Deineko V
Protein Pept Lett; 2006; 13(7):687-91. PubMed ID: 17018011
[TBL] [Abstract][Full Text] [Related]
36. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
[TBL] [Abstract][Full Text] [Related]
37. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis.
Knies UE; Behrensdorf HA; Mitchell CA; Deutsch U; Risau W; Drexler HC; Clauss M
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12322-7. PubMed ID: 9770485
[TBL] [Abstract][Full Text] [Related]
38. Expression of EMAP II in the developing and adult mouse.
Knies UE; Kröger S; Clauss M
Apoptosis; 2000 Apr; 5(2):141-51. PubMed ID: 11232242
[TBL] [Abstract][Full Text] [Related]
39. Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma.
Lans TE; ten Hagen TL; van Horssen R; Wu PC; van Tiel ST; Libutti SK; Alexander HR; Eggermont AM
Ann Surg Oncol; 2002 Oct; 9(8):812-9. PubMed ID: 12374666
[TBL] [Abstract][Full Text] [Related]
40. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells.
Schluesener HJ; Seid K; Zhao Y; Meyermann R
Glia; 1997 Aug; 20(4):365-72. PubMed ID: 9262239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
